Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

Maertens, J.; Raad, Issam; Petrikkos, G.; Boogaerts, Marc; Selleslag, Dominik; Bo Petersen, Finn; A. Sable, Carole; A. Kartsonis, Nicholas; Ngai, Angela; Taylor, Arlene; F. Patterson, Thomas; W. Denning, David; J. Walsh, Thomas; Salvage Aspergillosis Study Group, Caspofungin

doi:10.1086/423381

Public

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

Published in Clinical Infectious Diseases • Nov 19, 2004

Authors:

J. Maertens

Issam Raad

G. Petrikkos

Abstract

BACKGROUND: Invasive aspergillosis (IA) is an important cause of morbidity and mortality among immunocompromised patients. Echinocandins are novel antifungal molecules with in vitro and in vivo activity against Aspergillus species. METHODS: We investigated the efficacy and safety of caspofungin in t...

Subject

Caspofungin

Aspergillosis

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!